Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
2 Reasons to Like HALO and 1 to Stay Skeptical
July 10, 2026
Halozyme (HALO) Q1 2026 Earnings Transcript ↗
May 11, 2026
Halozyme Therapeutics Q1 Earnings Call Highlights ↗
May 11, 2026
3 Cash-Producing Stocks with Exciting Potential
April 10, 2026
2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore
April 09, 2026
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
April 08, 2026
2 Reasons to Like HALO (and 1 Not So Much)
February 24, 2026
Frequently Asked QuestionsIs Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 82.27
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 08/03/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 11.71B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
